Allogene Therapeutics Inc. (NASDAQ:ALLO) major shareholder Group Holdings (Sbs) Advis Tpg purchased 675,000 shares of the business’s stock in a transaction dated Monday, October 15th. The shares were purchased at an average price of $18.00 per share, with a total value of $12,150,000.00. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
ALLO traded down $0.89 during trading on Wednesday, reaching $24.98. 2,139,500 shares of the company were exchanged, compared to its average volume of 2,946,300. Allogene Therapeutics Inc. has a 12-month low of $21.67 and a 12-month high of $27.72.
Featured Story: Fundamental Analysis – How It Helps Investors
Receive News & Ratings for Allogene Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allogene Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.